# Mass Balance and Absolute Bioavailability Study of RO7049389 in Healthy Volunteers

> **NCT04729309** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 22 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [12C] RO7049389
- **DRUG:** [13C] RO7049389
- **DRUG:** [14C] RO7049389

## Key facts

- **NCT ID:** NCT04729309
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2021-06-14
- **Final completion:** 2021-06-14
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04729309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04729309, "Mass Balance and Absolute Bioavailability Study of RO7049389 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04729309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*